Lawrence Eichenfield's Net Worth

$0

Estimate Recalculated Apr 2, 2024 05:36PM EST

Who is Lawrence Eichenfield?

Lawrence Eichenfield does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Verrica Pharmaceuticals Inc., and Forte Biosciences, Inc..

SEC CIK

Lawrence Eichenfield's CIK is 0001814892

Past Insider Trading and Trends

2021 was Lawrence Eichenfield's most active year for acquiring shares with 3 total transactions. Lawrence Eichenfield's most active month to acquire stocks was the month of May. 2020 saw Lawrence Eichenfield paying a total of $0.00 for 47,502 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Verrica Pharmaceuticals Inc. (VRCA) Snapshot price: $5.21

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 8
Form 4
—
0
—
—
0
Jun 9
Form 4/A
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Aug 1
Form 3
—
0
—
—
0
No matching records found

Forte Biosciences, Inc. (FBRX) Snapshot price: $0.571

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Sep 19
Form 4
—
0
—
—
0
Jun 1
Form 4
—
0
—
—
0
Feb 23
Form 4
—
0
—
—
0
May 28
Form 4
—
0
—
—
0
Jun 15
Form 3
—
0
—
—
0
No matching records found